The risk or severity of adverse effects can be increased when diltiazem is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when bumetanide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when trimipramine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when clorazepate is combined with paroxetine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when Lacidipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when oxazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with irbesartan.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when oxazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when oxazepam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when haloperidol is combined with proparacaine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when haloperidol is combined with Halazepam.


The risk or severity of adverse effects can be increased when haloperidol is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when fludiazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when celecoxib is combined with Icatibant.


The risk or severity of adverse effects can be increased when temazepam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Clobetasone.


The risk or severity of adverse effects can be increased when isradipine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when isradipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with prilocaine.


The risk or severity of adverse effects can be increased when methylphenidate is combined with imipramine.


The risk or severity of adverse effects can be increased when loxapine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when benazepril is combined with clonidine.


The risk or severity of adverse effects can be increased when trandolapril is combined with bumetanide.


The risk or severity of adverse effects can be increased when mecamylamine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with captopril.


The risk or severity of adverse effects can be increased when Sacubitril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when butabarbital is combined with Milnacipran.


The risk or severity of adverse effects can be increased when clozapine is combined with Melatonin.


The risk or severity of adverse effects can be increased when trandolapril is combined with quinapril.


The risk or severity of adverse effects can be increased when enflurane is combined with imipramine.


The risk or severity of adverse effects can be increased when alclofenac is combined with triamcinolone.


The risk or severity of adverse effects can be increased when clenbuterol is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Droxicam is combined with flunisolide.


The risk or severity of adverse effects can be increased when secobarbital is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Pizotifen.


The risk or severity of adverse effects can be increased when enflurane is combined with loratadine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when morphine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when thioridazine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Agomelatine is combined with phenytoin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when tubocurarine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when methazolamide is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with mesalamine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with felbamate.


The risk or severity of adverse effects can be increased when pentazocine is combined with furazolidone.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when alprazolam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with zaleplon.


The risk or severity of adverse effects can be increased when butamben is combined with desipramine.


The risk or severity of adverse effects can be increased when thioridazine is combined with dibucaine.


The risk or severity of adverse effects can be increased when thioridazine is combined with metolazone.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when linezolid is combined with perphenazine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when tretinoin is combined with Eplerenone.


The risk or severity of adverse effects can be increased when tretinoin is combined with methazolamide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when selegiline is combined with isoetharine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when butabarbital is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when loxapine is combined with secobarbital.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Tadalafil.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Articaine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with antipyrine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with diazepam.


The risk or severity of adverse effects can be increased when Nabilone is combined with bumetanide.


The risk or severity of adverse effects can be increased when nabumetone is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when enflurane is combined with chlormezanone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with reserpine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with clidinium.


The risk or severity of adverse effects can be increased when temazepam is combined with prilocaine.


The risk or severity of adverse effects can be increased when temazepam is combined with isoflurane.


The risk or severity of adverse effects can be increased when bupivacaine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when terazosin is combined with Riociguat.


The risk or severity of adverse effects can be increased when temazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when Lacidipine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when nicergoline is combined with sulfisoxazole.


The risk or severity of adverse effects can be increased when scopolamine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when bumetanide is combined with tobramycin.


The risk or severity of adverse effects can be increased when indomethacin is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when quazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when zopiclone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when triazolam is combined with Retigabine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Perampanel.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with mefloquine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with methazolamide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Eplerenone.


The risk or severity of adverse effects can be increased when levorphanol is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when triflupromazine is combined with dibucaine.


The risk or severity of adverse effects can be increased when midazolam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with estrone.


The risk or severity of adverse effects can be increased when gabapentin is combined with butamben.


The risk or severity of adverse effects can be increased when thioridazine is combined with triamterene.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with etodolac.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when biperiden is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when meclizine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when gabapentin is combined with simvastatin.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with acemetacin.


The risk or severity of adverse effects can be increased when selegiline is combined with brimonidine.


The risk or severity of adverse effects can be increased when gabapentin is combined with dyclonine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Normethadone.


The risk or severity of adverse effects can be increased when gabapentin is combined with propoxyphene.


The risk or severity of adverse effects can be increased when indomethacin is combined with Apremilast.


The risk or severity of adverse effects can be increased when selegiline is combined with sotalol.


The risk or severity of adverse effects can be increased when zopiclone is combined with thiopental.


The risk or severity of adverse effects can be increased when celecoxib is combined with Apremilast.


The risk or severity of adverse effects can be increased when lithium ion is combined with scopolamine.


The risk or severity of adverse effects can be increased when pergolide is combined with risperidone.


The risk or severity of adverse effects can be increased when zopiclone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when glutethimide is combined with amoxapine.


The risk or severity of adverse effects can be increased when furosemide is combined with streptozocin.


The risk or severity of adverse effects can be increased when pimozide is combined with dyclonine.


The risk or severity of adverse effects can be increased when glutethimide is combined with nortriptyline.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when codeine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Masoprocol.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with ramipril.


The risk or severity of adverse effects can be increased when mesalamine is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when mesalamine is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when codeine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when codeine is combined with methazolamide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when cabergoline is combined with oxymetholone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with dibucaine.


The risk or severity of adverse effects can be increased when trimetrexate is combined with cilnidipine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when meprobamate is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when rasagiline is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Propiverine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when cocaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when topiramate is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when meprobamate is combined with phenobarbital.


The risk or severity of adverse effects can be increased when butabarbital is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with dexamethasone.


The risk or severity of adverse effects can be increased when midazolam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with prazepam.


The risk or severity of adverse effects can be increased when diclofenac is combined with Olopatadine.


The risk or severity of adverse effects can be increased when flunarizine is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when venlafaxine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when venlafaxine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with propranolol.


The risk or severity of adverse effects can be increased when salicylic acid is combined with antipyrine.


The risk or severity of adverse effects can be increased when bifonazole is combined with nimodipine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with etizolam.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Sacubitril.


The risk or severity of adverse effects can be increased when butalbital is combined with meclizine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when aspirin is combined with dexamethasone.


The risk or severity of adverse effects can be increased when retinol is combined with Alitretinoin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Retigabine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with nadolol.


The risk or severity of adverse effects can be increased when propofol is combined with triazolam.


The risk or severity of adverse effects can be increased when tenoxicam is combined with celecoxib.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when biperiden is combined with oxycodone.


The risk or severity of adverse effects can be increased when brotizolam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when barnidipine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with EDTA.


The risk or severity of adverse effects can be increased when pentobarbital is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when levorphanol is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when salicylic acid is combined with dorzolamide.


The risk or severity of adverse effects can be increased when propofol is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with amcinonide.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with haloperidol.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with butamben.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with bepridil.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when minoxidil is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when spironolactone is combined with metolazone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when difluprednate is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Isavuconazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Apremilast is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Naftifine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Melatonin is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with thiamylal.


The risk or severity of adverse effects can be increased when hydromorphone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Bivalirudin is combined with meperidine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with ritodrine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with nabumetone.


The risk or severity of adverse effects can be increased when tubocurarine is combined with acetylcholine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when LISURIDE is combined with clomiphene.


The risk or severity of adverse effects can be increased when Benidipine is combined with simvastatin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with levodopa.


The risk or severity of adverse effects can be increased when ketamine is combined with flunarizine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when antipyrine is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with flumethasone.


The risk or severity of adverse effects can be increased when antipyrine is combined with prednisone.


The risk or severity of adverse effects can be increased when paramethasone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Articaine is combined with topiramate.


The risk or severity of adverse effects can be increased when quetiapine is combined with brotizolam.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when tolmetin is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when triamcinolone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with topiramate.


The risk or severity of adverse effects can be increased when nabumetone is combined with budesonide.


The risk or severity of adverse effects can be increased when brimonidine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with procaine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with trimipramine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with doxepin.


The risk or severity of adverse effects can be increased when naratriptan is combined with lithium ion.


The risk or severity of adverse effects can be increased when bromocriptine is combined with trandolapril.


The risk or severity of adverse effects can be increased when Olmesartan is combined with floctafenine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with baclofen.


The risk or severity of adverse effects can be increased when Tiotropium is combined with topiramate.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when scopolamine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when amcinonide is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with promethazine.


The risk or severity of adverse effects can be increased when amcinonide is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when bromazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when flumethasone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with nimodipine.


The risk or severity of adverse effects can be increased when METYROSINE is combined with Cariprazine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with paramethasone.


The risk or severity of adverse effects can be increased when barnidipine is combined with losartan.


The risk or severity of adverse effects can be increased when barnidipine is combined with thioridazine.


The risk or severity of adverse effects can be increased when morphine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when levorphanol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when meprobamate is combined with buspirone.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with sevoflurane.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with quinapril.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with sumatriptan.


The risk or severity of adverse effects can be increased when tacrolimus is combined with melphalan.


The risk or severity of adverse effects can be increased when tacrolimus is combined with thalidomide.


The risk or severity of adverse effects can be increased when perphenazine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when methysergide is combined with nilvadipine.


The risk or severity of adverse effects can be increased when isradipine is combined with triamterene.


The risk or severity of adverse effects can be increased when methysergide is combined with Fosaprepitant.


The risk or severity of adverse effects can be increased when oxazepam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when oxazepam is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when leflunomide is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when oxazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when Clobetasone is combined with Deferasirox.


The risk or severity of adverse effects can be increased when oxazepam is combined with sevoflurane.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with nadolol.


The risk or severity of adverse effects can be increased when lisinopril is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when suprofen is combined with desoximetasone.


The risk or severity of adverse effects can be increased when oxaprozin is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with penbutolol.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when pentamidine is combined with Pinaverium.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with dantrolene.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with azelastine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with niflumic acid.


The risk or severity of adverse effects can be increased when quetiapine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when rasagiline is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Eletriptan is combined with cabergoline.


The risk or severity of adverse effects can be increased when rasagiline is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when rasagiline is combined with Eplerenone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with clozapine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with brotizolam.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Olsalazine.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Normethadone.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when imipramine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when memantine is combined with pilocarpine.


The risk or severity of adverse effects can be increased when nabumetone is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Tolcapone.


The risk or severity of adverse effects can be increased when imipramine is combined with maprotiline.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Droxicam.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with fluocinonide.


The risk or severity of adverse effects can be increased when antipyrine is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when triazolam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when clomipramine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when papaverine is combined with nadolol.


The risk or severity of adverse effects can be increased when propantheline is combined with codeine.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Flibanserin.


The risk or severity of adverse effects can be increased when labetalol is combined with Ephedrine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Dothiepin is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when estazolam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with Phenelzine.


The risk or severity of adverse effects can be increased when thalidomide is combined with nadolol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with nifedipine.


The risk or severity of adverse effects can be increased when tolazoline is combined with Tolcapone.


The risk or severity of adverse effects can be increased when benzoic acid is combined with flunarizine.


The risk or severity of adverse effects can be increased when Amrinone is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when acebutolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when amifostine is combined with selegiline.


The risk or severity of adverse effects can be increased when clozapine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when meprobamate is combined with secobarbital.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with suprofen.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with loteprednol.


The risk or severity of adverse effects can be increased when haloperidol is combined with Perospirone.


The risk or severity of adverse effects can be increased when irbesartan is combined with Clevidipine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with levodopa.


The risk or severity of adverse effects can be increased when pancuronium is combined with pentazocine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when enalapril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when carvedilol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when quazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when Mometasone is combined with Demecarium.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Articaine.


The risk or severity of adverse effects can be increased when protriptyline is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when amphotericin b is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when carprofen is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Melatonin is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with ILOPROST.


The risk or severity of adverse effects can be increased when citalopram is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when imipramine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with paroxetine.


The risk or severity of adverse effects can be increased when haloprogin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when lisinopril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when thiothixene is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Tramadol is combined with Fospropofol.


The risk or severity of adverse effects can be increased when labetalol is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when procaine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with meperidine.


The risk or severity of adverse effects can be increased when procaine is combined with prilocaine.


The risk or severity of adverse effects can be increased when Pinaverium is combined with simvastatin.


The risk or severity of adverse effects can be increased when procaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when HEROIN is combined with phenytoin.


The risk or severity of adverse effects can be increased when butorphanol is combined with Melatonin.


The risk or severity of adverse effects can be increased when Etidocaine is combined with citalopram.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Sacubitril.


The risk or severity of adverse effects can be increased when diclofenac is combined with equilin.


The risk or severity of adverse effects can be increased when furosemide is combined with D-mannitol.


The risk or severity of adverse effects can be increased when butorphanol is combined with promethazine.


The risk or severity of adverse effects can be increased when imipramine is combined with reserpine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when celecoxib is combined with Droxicam.


The risk or severity of adverse effects can be increased when Butethal is combined with clidinium.


The risk or severity of adverse effects can be increased when thioridazine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when diazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Perospirone.


The risk or severity of adverse effects can be increased when celecoxib is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when trazodone is combined with benzocaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ambroxol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with dibucaine.


The risk or severity of adverse effects can be increased when trazodone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with antipyrine.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with Efonidipine.


The risk or severity of adverse effects can be increased when meperidine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Clobetasone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when hydromorphone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when meperidine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when oxycodone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when oxycodone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when primidone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when oxycodone is combined with thiopental.


The risk or severity of adverse effects can be increased when propantheline is combined with oxymorphone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with zonisamide.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with brotizolam.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when maprotiline is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when ILOPROST is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with flunarizine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with tiagabine.


The risk or severity of adverse effects can be increased when doxepin is combined with Cariprazine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with sevoflurane.


The risk or severity of adverse effects can be increased when pentazocine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Eprosartan.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with suprofen.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Icatibant.


The risk or severity of adverse effects can be increased when acebutolol is combined with captopril.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when proparacaine is combined with etizolam.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Efonidipine is combined with thalidomide.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with ondansetron.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with bumetanide.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with quinapril.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when betaxolol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with flurazepam.


The risk or severity of adverse effects can be increased when hydroxyzine is combined with duloxetine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when HEROIN is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with antipyrine.


The risk or severity of adverse effects can be increased when clonidine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when risperidone is combined with procaine.


The risk or severity of adverse effects can be increased when zotepine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when clonidine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when practolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when irbesartan is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when amitriptyline is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when benazepril is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Asenapine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with amobarbital.


The risk or severity of adverse effects can be increased when tioconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when leflunomide is combined with fluocinonide.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Butethal.


The risk or severity of adverse effects can be increased when temazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with thiothixene.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when cocaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when epinephrine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when temazepam is combined with estazolam.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when trazodone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Nabilone is combined with venlafaxine.


The risk or severity of adverse effects can be increased when triazolam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when morphine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with sevoflurane.


The risk or severity of adverse effects can be increased when sevoflurane is combined with brotizolam.


The risk or severity of adverse effects can be increased when protriptyline is combined with Ramelteon.


The risk or severity of adverse effects can be increased when protriptyline is combined with formoterol.


The risk or severity of adverse effects can be increased when Ticagrelor is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when protriptyline is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with fosinopril.


The risk or severity of adverse effects can be increased when trandolapril is combined with salicylamide.


The risk or severity of adverse effects can be increased when sulpiride is combined with brotizolam.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with salicylamide.


The risk or severity of adverse effects can be increased when promazine is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when Pramocaine is combined with primidone.


The risk or severity of adverse effects can be increased when metoprolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with cetirizine.


The risk or severity of adverse effects can be increased when temazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Metixene.


The risk or severity of adverse effects can be increased when Almotriptan is combined with lithium ion.


The risk or severity of adverse effects can be increased when sevoflurane is combined with butamben.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Pipamperone is combined with baclofen.


The risk or severity of adverse effects can be increased when azelastine is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when suprofen is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when butabarbital is combined with flurazepam.


The risk or severity of adverse effects can be increased when secobarbital is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Pipamperone is combined with hydralazine.


The risk or severity of adverse effects can be increased when secobarbital is combined with oxprenolol.


The risk or severity of adverse effects can be increased when tetracaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when secobarbital is combined with prazepam.


The risk or severity of adverse effects can be increased when terazosin is combined with hydralazine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with cetirizine.


The risk or severity of adverse effects can be increased when Tramadol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when pancuronium is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with protriptyline.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Nebivolol.


The risk or severity of adverse effects can be increased when mepivacaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when diazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Conivaptan is combined with pramipexole.


The risk or severity of adverse effects can be increased when ritodrine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when Propiverine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with vigabatrin.


The risk or severity of adverse effects can be increased when enalapril is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with benzocaine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Droxicam.


The risk or severity of adverse effects can be increased when sulindac is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when promazine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when benzocaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with meclizine.


The risk or severity of adverse effects can be increased when sulindac is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with quetiapine.


The risk or severity of adverse effects can be increased when cilazapril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when temazepam is combined with quetiapine.


The risk or severity of adverse effects can be increased when cilazapril is combined with Droxicam.


The risk or severity of adverse effects can be increased when nortriptyline is combined with zonisamide.


The risk or severity of adverse effects can be increased when oxycodone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with zonisamide.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with betamethasone.


The risk or severity of adverse effects can be increased when tamoxifen is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Asunaprevir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when clotrimazole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when clomipramine is combined with reserpine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Apremilast.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with tiagabine.


The risk or severity of adverse effects can be increased when betamethasone is combined with decamethonium.


The risk or severity of adverse effects can be increased when indomethacin is combined with fenbufen.


The risk or severity of adverse effects can be increased when indomethacin is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Almotriptan is combined with loxapine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with nicardipine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Retigabine.


The risk or severity of adverse effects can be increased when propantheline is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when fosinopril is combined with Sacubitril.


The risk or severity of adverse effects can be increased when isoflurane is combined with tolazoline.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with meclizine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when sulpiride is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when procaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Butoconazole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when tiapride is combined with imipramine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when tiapride is combined with loratadine.


The risk or severity of adverse effects can be increased when amisulpride is combined with Fospropofol.


The risk or severity of adverse effects can be increased when thiopental is combined with Etidocaine.


The risk or severity of adverse effects can be increased when clorazepate is combined with gabapentin.


The risk or severity of adverse effects can be increased when temazepam is combined with enflurane.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with flunisolide.


The risk or severity of adverse effects can be increased when triazolam is combined with paroxetine.


The risk or severity of adverse effects can be increased when oxazepam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when cabergoline is combined with ifosfamide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with tacrolimus.


The risk or severity of adverse effects can be increased when sulindac is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when sulindac is combined with salicylic acid.


The risk or severity of adverse effects can be increased when isoflurane is combined with butalbital.


The risk or severity of adverse effects can be increased when etizolam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when benztropine is combined with propantheline.


The risk or severity of adverse effects can be increased when loxapine is combined with estazolam.


The risk or severity of adverse effects can be increased when pentobarbital is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when triprolidine is combined with flunarizine.


The risk or severity of adverse effects can be increased when butorphanol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when pergolide is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when lidocaine is combined with trazodone.


The risk or severity of adverse effects can be increased when pergolide is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when haloperidol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when mesoridazine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ketorolac is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when fenbufen is combined with paramethasone.


The risk or severity of adverse effects can be increased when ketorolac is combined with paramethasone.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with quetiapine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with thiopental.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with felbamate.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with baclofen.


The risk or severity of adverse effects can be increased when Glubionate calcium is combined with Calcifediol.


The risk or severity of adverse effects can be increased when butorphanol is combined with Efonidipine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Retigabine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with clidinium.


The risk or severity of adverse effects can be increased when ATROPINE is combined with levorphanol.


The risk or severity of adverse effects can be increased when clomipramine is combined with Bretylium.


The risk or severity of adverse effects can be increased when propofol is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when sertraline is combined with rasagiline.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with butalbital.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when midazolam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when pergolide is combined with lidocaine.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Toloxatone.


The risk or severity of adverse effects can be increased when tetracaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when quinapril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when sertraline is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with imipramine.


The risk or severity of adverse effects can be increased when ropinirole is combined with hydralazine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with loratadine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with meperidine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when NEOSTIGMINE is combined with acetylcholine.


The risk or severity of adverse effects can be increased when buprenorphine is combined with methylene blue.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with trimipramine.


The risk or severity of adverse effects can be increased when ipratropium is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Halazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when chloroquine is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with Deferasirox.


The risk or severity of adverse effects can be increased when propantheline is combined with meperidine.


The risk or severity of adverse effects can be increased when labetalol is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when leflunomide is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when indomethacin is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when ketamine is combined with efavirenz.


The risk or severity of adverse effects can be increased when estazolam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when oxycodone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when oxycodone is combined with tiagabine.


The risk or severity of adverse effects can be increased when oxycodone is combined with ondansetron.


The risk or severity of adverse effects can be increased when Toloxatone is combined with terbutaline.


The risk or severity of adverse effects can be increased when benzocaine is combined with tiapride.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with HEROIN.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when isoflurane is combined with nifedipine.


The risk or severity of adverse effects can be increased when isoflurane is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Riociguat.


The risk or severity of adverse effects can be increased when oxprenolol is combined with tiagabine.


The risk or severity of adverse effects can be increased when phentolamine is combined with triamterene.


The risk or severity of adverse effects can be increased when pentazocine is combined with halothane.


The risk or severity of adverse effects can be increased when oxprenolol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when diflunisal is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when oxprenolol is combined with zonisamide.


The risk or severity of adverse effects can be increased when baclofen is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when fludiazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when cabergoline is combined with antipyrine.


The risk or severity of adverse effects can be increased when Articaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when baclofen is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when valsartan is combined with Eprosartan.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Conivaptan.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with lithium ion.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with scopolamine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with cetirizine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with protriptyline.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when Nepafenac is combined with flunisolide.


The risk or severity of adverse effects can be increased when leflunomide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when sulfamethoxazole is combined with methotrexate.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with fosinopril.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with levodopa.


The risk or severity of adverse effects can be increased when amoxapine is combined with dantrolene.


The risk or severity of adverse effects can be increased when phenytoin is combined with lithium ion.


The risk or severity of adverse effects can be increased when Icatibant is combined with fenbufen.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with oxycodone.


The risk or severity of adverse effects can be increased when buspirone is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with olanzapine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Rivaroxaban is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with tizanidine.


The risk or severity of adverse effects can be increased when buspirone is combined with bromazepam.


The risk or severity of adverse effects can be increased when celiprolol is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Tramadol is combined with temazepam.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Phenelzine.


The risk or severity of adverse effects can be increased when ipratropium is combined with scopolamine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with salicylic acid.


The risk or severity of adverse effects can be increased when aspirin is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with dibucaine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Fospropofol.


The risk or severity of adverse effects can be increased when carvedilol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Nepafenac.


The risk or severity of adverse effects can be increased when epirizole is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when quetiapine is combined with zonisamide.


The risk or severity of adverse effects can be increased when aminophylline is combined with Indacaterol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with loratadine.


The risk or severity of adverse effects can be increased when quetiapine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when codeine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with phenytoin.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with amisulpride.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Etidocaine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Etomidate.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with donepezil.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with bupivacaine.


The risk or severity of adverse effects can be increased when temazepam is combined with zopiclone.


The risk or severity of adverse effects can be increased when Torasemide is combined with losartan.


The risk or severity of adverse effects can be increased when nabumetone is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Tasimelteon is combined with paroxetine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with nifedipine.


The risk or severity of adverse effects can be increased when propofol is combined with etizolam.


The risk or severity of adverse effects can be increased when tenoxicam is combined with DESONIDE.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with enoxacin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Toloxatone is combined with Isometheptene.


The risk or severity of adverse effects can be increased when benztropine is combined with ipratropium.


The risk or severity of adverse effects can be increased when quinidine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when nicergoline is combined with etoposide.


The risk or severity of adverse effects can be increased when clorazepate is combined with amisulpride.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Aliskiren.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Eplerenone.


The risk or severity of adverse effects can be increased when clorazepate is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Rotigotine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when diclofenac is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Melatonin.


The risk or severity of adverse effects can be increased when chloroquine is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with promethazine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with clonazepam.


The risk or severity of adverse effects can be increased when Phenelzine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Apremilast is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when meperidine is combined with quetiapine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Deferasirox.


The risk or severity of adverse effects can be increased when meperidine is combined with ketamine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Pizotifen.


The risk or severity of adverse effects can be increased when proparacaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Fospropofol.


The risk or severity of adverse effects can be increased when ketorolac is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with droperidol.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with azelastine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Difenoxin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with zopiclone.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with carprofen.


The risk or severity of adverse effects can be increased when buspirone is combined with zotepine.


The risk or severity of adverse effects can be increased when buspirone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Bretylium.


The risk or severity of adverse effects can be increased when pimozide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with bupivacaine.


The risk or severity of adverse effects can be increased when estazolam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when gabapentin is combined with flunarizine.


The risk or severity of adverse effects can be increased when estazolam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when secobarbital is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when temazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when gabapentin is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with thalidomide.


The risk or severity of adverse effects can be increased when cetirizine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Isoconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when captopril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when ketoconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when Tramadol is combined with secobarbital.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when methylene blue is combined with metaproterenol.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when midazolam is combined with flunarizine.


The risk or severity of adverse effects can be increased when norepinephrine is combined with dopamine.


The risk or severity of adverse effects can be increased when acetazolamide is combined with phenytoin.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when cabergoline is combined with paramethasone.


The risk or severity of adverse effects can be increased when methysergide is combined with vincristine.


The risk or severity of adverse effects can be increased when losartan is combined with Nebivolol.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Clofarabine.


The risk or severity of adverse effects can be increased when resveratrol is combined with Tixocortol.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when trimipramine is combined with desipramine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with ouabain.


The risk or severity of adverse effects can be increased when morphine is combined with benazepril.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with methyldopa.


The risk or severity of adverse effects can be increased when morphine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when thioridazine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when thioridazine is combined with benzocaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when nicergoline is combined with mequitazine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Atazanavir.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when iopromide is combined with metformin.


The risk or severity of adverse effects can be increased when clorazepate is combined with triflupromazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with pentazocine.


The risk or severity of adverse effects can be increased when meprobamate is combined with trazodone.


The risk or severity of adverse effects can be increased when methysergide is combined with zafirlukast.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when quazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when glutethimide is combined with trimipramine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with indomethacin.


The risk or severity of adverse effects can be increased when scopolamine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when butabarbital is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Perospirone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Apremilast is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when celecoxib is combined with halcinonide.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Clobetasone.


The risk or severity of adverse effects can be increased when celecoxib is combined with difluprednate.


The risk or severity of adverse effects can be increased when Apremilast is combined with Droxicam.


The risk or severity of adverse effects can be increased when Agomelatine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Ecabet.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Gallium nitrate.


The risk or severity of adverse effects can be increased when methylergonovine is combined with dexamethasone.


The risk or severity of adverse effects can be increased when diazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when nitrazepam is combined with sertraline.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Tramadol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Articaine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with irbesartan.


The risk or severity of adverse effects can be increased when indomethacin is combined with desoximetasone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with felodipine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Paliperidone.


The risk or severity of adverse effects can be increased when olanzapine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when olanzapine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when thiopental is combined with flunarizine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with formestane.


The risk or severity of adverse effects can be increased when LISURIDE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when imipramine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with ethotoin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with carisoprodol.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with prilocaine.


The risk or severity of adverse effects can be increased when lisinopril is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when trazodone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when tretinoin is combined with trandolapril.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with methazolamide.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Eplerenone.


The risk or severity of adverse effects can be increased when triprolidine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when pargyline is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when butalbital is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Articaine is combined with baclofen.


The risk or severity of adverse effects can be increased when propoxyphene is combined with maprotiline.


The risk or severity of adverse effects can be increased when propantheline is combined with quinidine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with mesoridazine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Nintedanib.


The risk or severity of adverse effects can be increased when amobarbital is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when lithium ion is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when duloxetine is combined with tiapride.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Tiotropium is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with niflumic acid.


The risk or severity of adverse effects can be increased when clorazepate is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with carvedilol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with goserelin.


The risk or severity of adverse effects can be increased when loteprednol is combined with Demecarium.


The risk or severity of adverse effects can be increased when levorphanol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when meprobamate is combined with dantrolene.


The risk or severity of adverse effects can be increased when Etidocaine is combined with imipramine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Etidocaine is combined with loratadine.


The risk or severity of adverse effects can be increased when meprobamate is combined with estazolam.


The risk or severity of adverse effects can be increased when procaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when sulpiride is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with medrysone.


The risk or severity of adverse effects can be increased when Tiotropium is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when trandolapril is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Naftifine.


The risk or severity of adverse effects can be increased when Mometasone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when thiothixene is combined with tiagabine.


The risk or severity of adverse effects can be increased when thiothixene is combined with cocaine.


The risk or severity of adverse effects can be increased when paramethasone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Retigabine.


The risk or severity of adverse effects can be increased when Risedronic acid is combined with simvastatin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Halazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when thiothixene is combined with zonisamide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when methyldopa is combined with nadolol.


The risk or severity of adverse effects can be increased when quinapril is combined with resveratrol.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when methysergide is combined with Tramadol.


The risk or severity of adverse effects can be increased when bromazepam is combined with butamben.


The risk or severity of adverse effects can be increased when methysergide is combined with erythromycin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when nefazodone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when buspirone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with captopril.


The risk or severity of adverse effects can be increased when nicotinic acid is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when cilazapril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when miconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Pipamperone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with tetracaine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Fosamprenavir.


The risk or severity of adverse effects can be increased when methylergonovine is combined with bifonazole.


The risk or severity of adverse effects can be increased when cilnidipine is combined with indapamide.


The risk or severity of adverse effects can be increased when furazolidone is combined with methadone.


The risk or severity of adverse effects can be increased when buprenorphine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with fenoldopam.


The risk or severity of adverse effects can be increased when ritonavir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when bromocriptine is combined with fosinopril.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when prazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when buspirone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when irbesartan is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when orphenadrine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when gabapentin is combined with sevoflurane.


The risk or severity of adverse effects can be increased when methylphenidate is combined with clomipramine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with terazosin.


The risk or severity of adverse effects can be increased when butalbital is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with spironolactone.


The risk or severity of adverse effects can be increased when perphenazine is combined with butalbital.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with efavirenz.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when midazolam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Carbetocin is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Lacidipine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Fospropofol.